X0306 4 2018-12-21 0 0000887151 Capstone Therapeutics Corp. CAPS 0001201333 SUBIN NEIL S 3300 SOUTH DIXIE HIGHWAY SUITE 1-365 WEST PALM BEACH FL 33405 0 0 1 0 Common Stock 2018-12-21 4 S 0 206000 0.052 D 2708484 I By MBM - Trust A-4 Common Stock 2018-12-21 4 P 0 103000 0.052 A 727100 I By LIMFAM LLC Common Stock 2914484 I By LIM III - Trust A-4 Common Stock 641218 I By Trust C - Lloyd I. Miller Common Stock 90344 I By Trust D - Lloyd I. Miller Common Stock 472792 I By Milfam II L.P. The reported transaction involved a sale of a total of 206,000 shares of Capstone Therapeutics Corp. ("Capstone") common stock by MBM - Trust A-4, which were acquired by LIMFAM LLC and another private purchaser at a privately negotiated price equal to $0.052 per share. The reporting person may be deemed to have voting and dispositive control over shares held by MBM - Trust A-4 and LIMFAM LLC. The reporting person believes that the reported transaction constitutes a change in the form of beneficial ownership without changing the reporting person's pecuniary interest in such securities and was exempt from Section 16 of the Act pursuant to Rule 16a-13. Except for possessing voting and dispositive power, the reporting person disclaims any other beneficial ownership of, and specifically any pecuniary interest in, the securities reported herein. This filing is not, and shall not be deemed, an admission (and the reporting person expressly disclaims) that the reporting person is, for purposes of Rule 16a-1(a)(2) under Section 16 of the Securities Exchange Act of 1934, the beneficial owner of any equity securities covered by this filing. The reporting person succeeded to the position of President and Manager of MILFAM LLC, which serves as manager, general partner, or investment advisor of a number of entities formerly managed or advised by the late Lloyd I. Miller, III. The reporting person also serves as trustee of a number of Miller family trusts. /s/ Paul N. Silverstein Attorney-in-fact 2018-12-28